Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Alvarez

Showing results (521-530 of 644) with videos related to

Pageof 65
Sort By:
Gynecologic Oncology|January 24, 2009
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rashRussell J Schilder, Harsh B Pathak, Anna E Lokshin, et al.
Obstetrics and Gynecology|May 2, 2008
Lynch syndrome in women less than 50 years of age with endometrial cancerKellie S Matthews, Jacob M Estes, Michael G Conner, et al.
American Journal of Respiratory Cell and Molecular Biology|October 6, 2001
Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammationB U Gajewska, F K Swirski, D Alvarez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancerW O Arafat, J Gómez-Navarro, J Xiang, et al.
Gynecologic Oncology|June 13, 2013
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancerKenneth H Kim, Igor P Dmitriev, Souheil Saddekni, et al.
Biopharmaceutics & Drug Disposition|July 13, 2004
Topical disposition of two strengths of a 125I-rhEGF jelly in rat skin woundsJ Duconge, P A Prats, C Valenzuela, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenovirusesAnna Kanerva, Minghui Wang, Gerd J Bauerschmitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinomaP J Mahasreshti, J G Navarro, M Kataram, et al.
Gynecologic Oncology|November 1, 1994
LLETZ is an acceptable alternative to diagnostic cold-knife conizationR W Naumann, M C Bell, R D Alvarez, et al.
Translational Lung Cancer Research|February 10, 2023
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancerEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
Pageof 65

Showing results (521-530 of 644) with videos related to

Sort By:
Pageof 65
Gynecologic Oncology|January 24, 2009
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rashRussell J Schilder, Harsh B Pathak, Anna E Lokshin, et al.
Obstetrics and Gynecology|May 2, 2008
Lynch syndrome in women less than 50 years of age with endometrial cancerKellie S Matthews, Jacob M Estes, Michael G Conner, et al.
American Journal of Respiratory Cell and Molecular Biology|October 6, 2001
Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammationB U Gajewska, F K Swirski, D Alvarez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancerW O Arafat, J Gómez-Navarro, J Xiang, et al.
Gynecologic Oncology|June 13, 2013
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancerKenneth H Kim, Igor P Dmitriev, Souheil Saddekni, et al.
Biopharmaceutics & Drug Disposition|July 13, 2004
Topical disposition of two strengths of a 125I-rhEGF jelly in rat skin woundsJ Duconge, P A Prats, C Valenzuela, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenovirusesAnna Kanerva, Minghui Wang, Gerd J Bauerschmitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinomaP J Mahasreshti, J G Navarro, M Kataram, et al.
Gynecologic Oncology|November 1, 1994
LLETZ is an acceptable alternative to diagnostic cold-knife conizationR W Naumann, M C Bell, R D Alvarez, et al.
Translational Lung Cancer Research|February 10, 2023
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancerEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
Pageof 65